Patents-Review.com
🔗 Permalink
Assignee profile:

Kronos Bio, Inc.

City:

San Mateo, California

Country:

United States

Published Applications:

12

Last publication date:

2025-06-12

Patent Grants:

10

Last grant date:

2025-04-01

Top Inventors for applications by Kronos Bio, Inc.

These are the the leading inventors for applications assigned to Kronos Bio, Inc.:

Recent patent applications by Kronos Bio, Inc.

Kronos Bio, Inc. based in San Mateo, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-06-12
US20250188084A1
Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY

 #2 | 2024-04-25
US20240132506A1
Chemistry; metallurgy

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CDK9 ACTIVITY

 #3 | 2023-05-25 ✅ Patent 12,263,163 granted on 2025-04-01
US20230158023A1
Human necessities

Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor

 #4 | 2023-03-30 ✅ Patent 12,152,037 granted on 2024-11-26
US20230098309A1
Chemistry; metallurgy

Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor

 #5 | 2022-08-25 ✅ Patent 12,122,781 granted on 2024-10-22
US20220267338A1
Chemistry; metallurgy

Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitors

 #6 | 2022-01-06 ✅ Patent 11,845,754 granted on 2023-12-19
US20220002305A1
Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity

 #7 | 2021-03-04 ✅ Patent 11,517,570 granted on 2022-12-06
US20210060011A1
Human necessities

Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine

 #8 | 2020-09-17 ✅ Patent 11,339,168 granted on 2022-05-24
US20200291035A1
Chemistry; metallurgy

Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors

 #9 | 2020-09-03 ✅ Patent 11,384,082 granted on 2022-07-12
US20200277293A1
Chemistry; metallurgy

Hydrates of polymorphs of 6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-A]pyrazin-8-amine bisemsylate as Syk inhibitors

 #10 | 2020-04-30 ✅ Patent 11,155,560 granted on 2021-10-26
US20200131189A1
Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrimidines for modulating CDK9 activity

 #11 | 2019-12-26 ✅ Patent 10,828,299 granted on 2020-11-10
US20190388419A1
Human necessities

Crystalline monomesylate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine

 #12 | 2019-04-25 ✅ Patent 10,842,803 granted on 2020-11-24
US20190117679A1
Human necessities

Imidazopyridines Syk inhibitors

Also check out Kronos Bio, Inc.'s (San Mateo, United States) applicant profile with 12 patent applications submitted.

AssigneeID:

319170 ⎘